We are live on ! Find out more
SCM

Stonepine Capital Management Portfolio holdings

AUM $250M
1-Year Est. Return 77.6%
This Fund
S&P 500
This Quarter Est. Return
-12.57%
1 Year Est. Return
+77.6%
3 Year Est. Return
+198.76%
5 Year Est. Return
+226.15%
10 Year Est. Return
+1,976.54%
AUM
$168M
AUM Growth
+$45.3M
Cap. Flow
+$93.3M
Cap. Flow %
55.55%
Top 10 Hldgs %
76.92%
Holding
27
New
11
Increased
8
Reduced
2
Closed
4

Top Buys

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$68.1M
2
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
+$13.5M
3
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$13M
4
SCLN
Sciclone Pharmaceuticals Inc
SCLN
+$12.5M
5
VCYT icon
Veracyte
VCYT
+$7.26M

Top Sells

1
TBRA
Tobira Therapeutics, Inc. Common Stock
TBRA
+$29.2M
2
QLTI
QLT Inc
QLTI
+$11.9M
3
CUTR
Cutera, Inc.
CUTR
+$4.18M
4
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$458K
5
VXRT
Vaxart
VXRT
+$53K

Sector Composition

1 Healthcare 87.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSCI
26
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
– –
-98,064
Closed -$458K
1
2

Similar funds

BIA
Bigelow Investment Advisors Portland, Maine $250M AUM 19.33% 1-Year Est. Return
TGP
TMT General Partner Hong Kong $250M AUM 6.05% 1-Year Est. Return
ER
EVR Research Richmond, Virginia $250M AUM 41.5% 1-Year Est. Return
FDDB
Fidelity D&D Bancorp Dunmore, Pennsylvania $249M AUM 18.9% 1-Year Est. Return
VM
VPR Management Houston, Texas $250M AUM 34.13% 1-Year Est. Return
PF
Parker Financial Silverdale, Washington $250M AUM 14.69% 1-Year Est. Return
SCM
Step Capital Management Singapore $249M AUM
CWM
Chicago Wealth Management Chicago, Illinois $251M AUM 45.31% 1-Year Est. Return

Stonepine Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Stonepine Capital Management held 27 positions worth $168M, up 37% from $123M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Stonepine Capital Management deployed $93.3M of net new capital in Q4 2016, opening 11 new positions and adding to 8 existing holdings. Its largest new stake was IVERIC bio, Inc. Common Stock: 2,292,900 shares worth $11.1M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 76% a quarter earlier.

On the sell side, the largest reduction was Cutera, Inc., an estimated $4.18M trimmed.

  • Stonepine Capital Management's largest Q4 2016 buy was IVERIC bio, Inc. Common Stock: 2,292,900 shares worth $11.1M.
  • Stonepine Capital Management added most to Societal CDMO, Inc. Common Stock in Q4 2016, an estimated $13M increase.
  • Stonepine Capital Management's biggest Q4 2016 reduction was Cutera, Inc., cutting an estimated $4.18M.
  • Stonepine Capital Management fully exited Tobira Therapeutics, Inc. Common Stock in Q4 2016, selling an estimated $29.2M.
  • Stonepine Capital Management's ten largest holdings make up 77% of its $168M portfolio in Q4 2016.
  • Stonepine Capital Management opened 11 new positions and closed 4 in Q4 2016.
  • Stonepine Capital Management's portfolio value rose 37% quarter-over-quarter to $168M.

Based on Stonepine Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.